Remei Blanco

735 total citations
18 papers, 465 citations indexed

About

Remei Blanco is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Remei Blanco has authored 18 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Remei Blanco's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Research Studies (5 papers). Remei Blanco is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Research Studies (5 papers). Remei Blanco collaborates with scholars based in Spain, Netherlands and Argentina. Remei Blanco's co-authors include J. Buesa, Joan Maurel, Andrés Poveda, Ana De Juan, P. Escudero, Javier García del Muro, Núria Laínez, Antonio Llombart‐Bosch, José Antonio López‐Guerrero and Silvia Calabuig‐Fariñas and has published in prestigious journals such as Journal of Clinical Oncology, Oncotarget and Lung Cancer.

In The Last Decade

Remei Blanco

17 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Remei Blanco Spain 9 330 261 149 83 59 18 465
Noriaki Tokumoto Japan 13 191 0.6× 97 0.4× 196 1.3× 130 1.6× 135 2.3× 35 468
Su-Shun Lo Taiwan 12 292 0.9× 130 0.5× 208 1.4× 90 1.1× 75 1.3× 12 578
Yulong He China 15 303 0.9× 93 0.4× 239 1.6× 129 1.6× 87 1.5× 46 521
Woo-Song Ha South Korea 8 120 0.4× 74 0.3× 125 0.8× 124 1.5× 29 0.5× 11 328
Hiroyuki Asama Japan 13 164 0.5× 52 0.2× 215 1.4× 165 2.0× 45 0.8× 68 403
Takaaki Hanyu Japan 11 244 0.7× 69 0.3× 241 1.6× 60 0.7× 42 0.7× 46 372
Marcus Fernando Kodama Pertille Ramos Brazil 18 682 2.1× 265 1.0× 380 2.6× 343 4.1× 47 0.8× 97 900
G. Bonfanti Italy 11 383 1.2× 138 0.5× 258 1.7× 63 0.8× 18 0.3× 24 487
Birendra Kumar Sah China 12 274 0.8× 126 0.5× 183 1.2× 85 1.0× 50 0.8× 31 425
Isao Kumano Japan 14 397 1.2× 189 0.7× 391 2.6× 110 1.3× 22 0.4× 31 609

Countries citing papers authored by Remei Blanco

Since Specialization
Citations

This map shows the geographic impact of Remei Blanco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Remei Blanco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Remei Blanco more than expected).

Fields of papers citing papers by Remei Blanco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Remei Blanco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Remei Blanco. The network helps show where Remei Blanco may publish in the future.

Co-authorship network of co-authors of Remei Blanco

This figure shows the co-authorship network connecting the top 25 collaborators of Remei Blanco. A scholar is included among the top collaborators of Remei Blanco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Remei Blanco. Remei Blanco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Blanco, Remei, Manuel Dómine, José Luis González, et al.. (2023). Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes. Lung Cancer. 183. 107318–107318. 5 indexed citations
2.
Riudavets, Mariona, Joaquim Bosch‐Barrera, Luis Cabezón‐Gutiérrez, et al.. (2021). Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma. Clinical & Translational Oncology. 23(12). 2560–2567. 7 indexed citations
3.
Franco, Fernando, Carlos García Girón, Manuel Dómine, et al.. (2020). Clinical and molecular characteristics of the patients in the liquid biopsy study in mEGFR-NSCLC in a Spanish population (OPH-1).. Journal of Clinical Oncology. 38(15_suppl). e21515–e21515. 1 indexed citations
4.
Franco, Fernando, Carlos García Girón, Manuel Dómine, et al.. (2020). ctDNA levels before treatment predict survival in non-small cell lung cancer patients treated with a tyrosine kinase inhibitor.. Journal of Clinical Oncology. 38(15_suppl). 9542–9542. 2 indexed citations
5.
Clavé, Sergi, Lara Pijuán, Marta Lorenzo, et al.. (2019). Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non–small-cell Lung Cancer: Implications of FISH-positive Patterns. Clinical Lung Cancer. 20(4). e421–e429. 33 indexed citations
6.
Sullivan, Ivana, Albert Altés, Margarita Majem, et al.. (2019). Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients. Angiogenesis. 22(3). 433–440. 28 indexed citations
7.
Morán, Teresa, Eudald Felip, Joaquim Bosch‐Barrera, et al.. (2018). Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer. Oncotarget. 9(43). 27074–27086. 4 indexed citations
8.
Karachaliou, Niki, Guillermo Crespo, Erika Aldeguer, et al.. (2017). Interferon-gamma (INFG), an important marker of response to immune checkpoint blockade (ICB) in non-small cell lung cancer (NSCLC) and melanoma patients.. Journal of Clinical Oncology. 35(15_suppl). 11504–11504. 12 indexed citations
9.
Guillén‐Ponce, Carmen, et al.. (2017). Delphi consensus of an expert committee in oncogeriatrics regarding comprehensive geriatric assessment in seniors with cancer in Spain. Journal of Geriatric Oncology. 9(4). 337–345. 14 indexed citations
10.
Blanco, Remei, et al.. (2016). Multidisciplinary treatment planning in elderly patients with cancer: a prospective observational study. The Journal of Community and Supportive Oncology. 14(11). 466–472. 5 indexed citations
11.
Juan, Óscar, José Vidal-Martínez, Remei Blanco, et al.. (2014). Quantification of circulating endothelial cells as a predictor of response to chemotherapy with platinum and pemetrexed in patients with advanced non-squamous non-small cell lung carcinoma. Clinical & Translational Oncology. 17(4). 281–288. 8 indexed citations
12.
Isla, Dolores, Mariano Provencio, Margarita Majem, et al.. (2012). Never-smoking women with lung cancer from the Spanish WORLD07 database.. Journal of Clinical Oncology. 30(15_suppl). 1531–1531. 1 indexed citations
13.
Casas, Francesc, Esther Jovell, Remei Blanco, et al.. (2012). Adapted ice cream as a nutritional supplement in cancer patients: impact on quality of life and nutritional status. Clinical & Translational Oncology. 14(1). 66–72. 21 indexed citations
14.
15.
16.
Martín‐Broto, Javier, Andrés Poveda, Antonio Llombart‐Bosch, et al.. (2005). Deletions Affecting Codons 557-558 of the c-KIT Gene Indicate a Poor Prognosis in Patients With Completely Resected Gastrointestinal Stromal Tumors: A Study by the Spanish Group for Sarcoma Research (GEIS). Journal of Clinical Oncology. 23(25). 6190–6198. 267 indexed citations
17.
Blanco, Remei, et al.. (2000). [Cavum lymphoma in a hemophilic patient with AIDS].. PubMed. 60(3). 351–3. 2 indexed citations
18.
Vadell, Catalina, Miguel Ángel Seguí, Serafín Morales, et al.. (1998). Anticachectic Efficacy of Megestrol Acetate at Different Doses and Versus Placebo in Patients With Neoplastic Cachexia. American Journal of Clinical Oncology. 21(4). 347–351. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noriaki Tokumoto Breakdown of academic impact, for papers by Su-Shun Lo Breakdown of academic impact, for papers by Yulong He Breakdown of academic impact, for papers by Woo-Song Ha Breakdown of academic impact, for papers by Hiroyuki Asama Breakdown of academic impact, for papers by Takaaki Hanyu Breakdown of academic impact, for papers by Marcus Fernando Kodama Pertille Ramos Breakdown of academic impact, for papers by G. Bonfanti Breakdown of academic impact, for papers by Birendra Kumar Sah Breakdown of academic impact, for papers by Isao Kumano
Rankless by CCL
2026